Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Fantini

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|July 21, 2022
Editorial: Engineered Targeted Cancer ImmunotherapiesMassimo Fantini, Roberto Bei
Expert Review of Vaccines|August 26, 2024
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cellsMassimo Fantini, Kwong Y Tsang, Philip M Arlen
Frontiers in Immunology|December 11, 2023
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapyMassimo Fantini, Philip Martin Arlen, Kwong Yok Tsang
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Reprogramming the immune system in IBDThomas T MacDonald, Anna Vossenkaemper, Massimo Fantini, et al.
Gastroenterology|August 2, 2003
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel diseaseLivia Biancone, Claudio Tosti, Francesca De Nigris, et al.
The Journal of Bone and Joint Surgery. American Volume|March 6, 2015
Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interactionUmberto Tarantino, Eleonora Piccirilli, Massimo Fantini, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileumLivia Biancone, Massimo Fantini, Claudio Tosti, et al.
Recent Patents on Inflammation & Allergy Drug Discovery|August 11, 2011
Dietary flavonoids: molecular mechanisms of action as anti- inflammatory agentsLaura Marzocchella, Massimo Fantini, Monica Benvenuto, et al.
Muscles, Ligaments and Tendons Journal|July 26, 2013
Tendon's ultrastructureIlaria Tresoldi, Francesco Oliva, Monica Benvenuto, et al.
Gastroenterology|April 3, 2003
TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cellsPhilip Rosenstiel, Massimo Fantini, Karen Bräutigam, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 21, 2022
Editorial: Engineered Targeted Cancer ImmunotherapiesMassimo Fantini, Roberto Bei
Expert Review of Vaccines|August 26, 2024
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cellsMassimo Fantini, Kwong Y Tsang, Philip M Arlen
Frontiers in Immunology|December 11, 2023
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapyMassimo Fantini, Philip Martin Arlen, Kwong Yok Tsang
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Reprogramming the immune system in IBDThomas T MacDonald, Anna Vossenkaemper, Massimo Fantini, et al.
Gastroenterology|August 2, 2003
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel diseaseLivia Biancone, Claudio Tosti, Francesca De Nigris, et al.
The Journal of Bone and Joint Surgery. American Volume|March 6, 2015
Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interactionUmberto Tarantino, Eleonora Piccirilli, Massimo Fantini, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileumLivia Biancone, Massimo Fantini, Claudio Tosti, et al.
Recent Patents on Inflammation & Allergy Drug Discovery|August 11, 2011
Dietary flavonoids: molecular mechanisms of action as anti- inflammatory agentsLaura Marzocchella, Massimo Fantini, Monica Benvenuto, et al.
Muscles, Ligaments and Tendons Journal|July 26, 2013
Tendon's ultrastructureIlaria Tresoldi, Francesco Oliva, Monica Benvenuto, et al.
Gastroenterology|April 3, 2003
TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cellsPhilip Rosenstiel, Massimo Fantini, Karen Bräutigam, et al.
Pageof 5